Showing results (391-400 of 458) with videos related to

Sort By:
Pageof 46
Pharmacology & Therapeutics|November 7, 2024
Lessons learned from 20 years of preclinical testing in pediatric cancersMalcolm A Smith, Peter J Houghton, Richard B Lock, et al.
Cancer Letters|December 20, 2015
MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastomaShile Zhang, Jun S Wei, Samuel Q Li, et al.
Cell Metabolism|September 22, 2015
MYC Disrupts the Circadian Clock and Metabolism in Cancer CellsBrian J Altman, Annie L Hsieh, Arjun Sengupta, et al.
Nature Communications|October 15, 2020
Pan-neuroblastoma analysis reveals age- and signature-associated driver alterationsSamuel W Brady, Yanling Liu, Xiaotu Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2021
The B7-H3-Targeting Antibody-Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor ModelsNathan M Kendsersky, Jarrett Lindsay, E Anders Kolb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2025
Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children's Oncology GroupFlorette K Hazard, Angus M S Toland, Serena Y Tan, et al.
Pediatric Blood & Cancer|October 27, 2006
The pediatric preclinical testing program: description of models and early testing resultsPeter J Houghton, Christopher L Morton, Chandra Tucker, et al.
Pageof 46